NIH grant cuts will axe clinical trials abroad — and could leave thousands without care
Diseases caused by HIV and drug-resistant tuberculosis could surge globally as a result of research-grant cuts made by the US National Institutes of Health. Credit: Jekesai Njikizana/AFP via Getty Amita Gupta has spent more than a decade planning and running a US$70-million trial to study a new tuberculosis drug, enrolling nearly 6,000 participants across 13 countries. It might all have...